Sjögren M - Search Results

1

CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.

Andreasen N, Sjögren M, Blennow K. Andreasen N, et al. Among authors: sjogren m. World J Biol Psychiatry. 2003 Oct;4(4):147-55. doi: 10.1080/15622970310029912. World J Biol Psychiatry. 2003. PMID: 14608585 Review.

2

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren M, Andreasen N, Blennow K. Sjögren M, et al. Clin Chim Acta. 2003 Jun;332(1-2):1-10. doi: 10.1016/s0009-8981(03)00121-9. Clin Chim Acta. 2003. PMID: 12763273 Review.

3

The link between cholesterol and Alzheimer's disease.

Sjögren M, Blennow K. Sjögren M, et al. World J Biol Psychiatry. 2005;6(2):85-97. doi: 10.1080/15622970510029795. World J Biol Psychiatry. 2005. PMID: 16156481 Review.

4

Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.

Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, Karlsson M, Nordlund A, Rolstad S, Warkentin S, Ben-Menachem E, Sjögren MJ. Merrill CA, et al. Among authors: sjogren mj. J Clin Psychiatry. 2006 Aug;67(8):1171-8. doi: 10.4088/jcp.v67n0801. J Clin Psychiatry. 2006. PMID: 16965193 Clinical Trial.

5

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

Tarkowski E, Issa R, Sjögren M, Wallin A, Blennow K, Tarkowski A, Kumar P. Tarkowski E, et al. Among authors: sjogren m. Neurobiol Aging. 2002 Mar-Apr;23(2):237-43. doi: 10.1016/s0197-4580(01)00285-8. Neurobiol Aging. 2002. PMID: 11804709

6

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

Sjögren M, Davidsson P, Wallin A, Granérus AK, Grundström E, Askmark H, Vanmechelen E, Blennow K. Sjögren M, et al. Dement Geriatr Cogn Disord. 2002;13(2):112-8. doi: 10.1159/000048642. Dement Geriatr Cogn Disord. 2002. PMID: 11844893

7

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients.

Davidsson P, Westman-Brinkmalm A, Nilsson CL, Lindbjer M, Paulson L, Andreasen N, Sjögren M, Blennow K. Davidsson P, et al. Among authors: sjogren m. Neuroreport. 2002 Apr 16;13(5):611-5. doi: 10.1097/00001756-200204160-00015. Neuroreport. 2002. PMID: 11973456

8

Biological correlates of clinical subgroups of Alzheimer's disease.

Sjögren M, Wikkelsö C, Ostling S, Wallin A, Blennow K. Sjögren M, et al. Dement Geriatr Cogn Disord. 2002;14(4):191-7. doi: 10.1159/000066025. Dement Geriatr Cogn Disord. 2002. PMID: 12411761

9

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins.

Davidsson P, Sjögren M, Andreasen N, Lindbjer M, Nilsson CL, Westman-Brinkmalm A, Blennow K. Davidsson P, et al. Among authors: sjogren m. Brain Res Mol Brain Res. 2002 Dec 30;109(1-2):128-33. doi: 10.1016/s0169-328x(02)00549-1. Brain Res Mol Brain Res. 2002. PMID: 12531522

10

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

Sáez-Valero J, Costell M, Sjögren M, Andreasen N, Blennow K, Luque JM. Sáez-Valero J, et al. Among authors: sjogren m. J Neurosci Res. 2003 Apr 1;72(1):132-6. doi: 10.1002/jnr.10554. J Neurosci Res. 2003. PMID: 12645087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters